Comparative pharmacokinetics of a single oral dose of two formulations of amlodipine: A randomized, single-blind, two-period, two-sequence, crossover study

Arzneimittel-Forschung/Drug Research

Volumn 58, Issue 7, 2008, Pages 323-327

  Pico, Jose Carlos ^a   Domínguez, Graciela ^a   Negri, Armando Luis ^b   Caubet, Juan Carlos ^b   Terragno, Norberto Antonio ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Laboratorios Casasco   (Argentina)

Author keywords

Amlodipine besylate, bioequivalence, pharmacokinetics; Calcium channel antagonists, dihydropyridine; CAS 111470 99 6

Indexed keywords

AMLODIPINE BESYLATE; PELMEC;

ADULT; ARGENTINA; ARTICLE; BIOEQUIVALENCE; CAUCASIAN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG FORMULATION; HEADACHE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; STOMACH ACID; TANDEM MASS SPECTROMETRY; VOLUNTEER;

EID: 49449099930     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296514     Document Type: Article

References (20)

1. Murdoch D, Heel RC. Amlodipine - A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in cardiovascular disease. Drugs. 1991;41 (3):478-505.
2. Little WC, Cheng CP. Vascular versus myocardial effects of calcium antagonists. Drugs. 1994;47 (Suppl 4):41-45.
3. Faulkner JK, DmcGibney D, Chasseaud LF, Perry JL, Taylor IW. The pharmacokinetics of amlodipine in healthy volunteers after intravenous, and oral doses and after 14 repeated oral doses once daily. Br J Clin Pharmacol. 1986;22: 21-25.
4. Meredithy PA, Elliott HL. Clinical pharmacokinetics of amlodipine. Clin Pharmacokinet. 1992;22(1):22-31.
5. Osterloh I. The safety of amlodipine. Am Heart J. 1989;118: 1114-1120.
6. Stangier J, Su C. Pharmacokinetics of Repeated Oral Doses of Amlodipine plus Telmisartan in Healthy Volunteers. J Clin Pharmacol. 2000;40:1347-1354.
7. Carvalho M, Oliveira CH, Mendes GD, Sucupira M, Moraes MEA, De Nucci G. Amlodipine bioequivalence Study: quantification by liquid chromatography coupled to tandem mass spectrometry. Biopharm Drug Dispos 2001;22:383-390.
8. Tatar S, Atmaca S. Determination of amlodipine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Biomed Sci Appl. 2001;758(2):305-310.
9. Bahrami G, Mirzaeei S. Simple and rapid HPLC method for determination of amlodipine in human serum with fluorescence detection and its use in pharmacokinetic studies. J Pharm Biomed Anal. 2004;36(1):163-168.
10. ANMAT Argentina. Dispositions 5330/97 and 3185/99. www.anmat.gov.ar.
11. Note for Guidance on the Investigation of Bioavailability and Bioequivalence. CPMP/EWP/QWP/1401/98 26 July 2001.
12. Food and Drug Administration. Bioavalilability and bioequivalence requirements. CFR Title 21, Volume 5 Parts 300/0499. Revised April 1, 2001.
13. Food and Drug Administration. Center of Drug Evaluation and Research. Guidance for Industry. Statistical approaches to establishing bioequivalence. Revised January 2001.
14. Schuirmann DA. Comparison of the two one-sided procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm. 1987;15 (6):657-680.
15. Hauck WW, Anderson SJ. A new statistical procedure for testing equivalence in two-group comparative bioavailability trials. Pharmacokinetic Biopharm. 1984;12:83-91.
16. Chow S, Liu JP editors. Design analysis: Bioavailability and bioequivalence studies. New York: Marcel Decker; 1982.
17. Food and Drug Administration Guidance. Statistical procedure for bioequivalence studies using standard 2-treatment cross-over design: Statement under 21 CFR 10.9. Rockville, MD: US Department of Health and Human Services; 1992.
18. Shumaker RC PKCALC: a BASIC interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metab Rev. 1986;7(3-4):331-348.
19. Amidon GL, Lennernas H , Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413-420.
20. Abad-Santos F, Novalbos J, Gálvez-Múgica MA, Gallego-Sandín S, Almeida S, Valleé F, et al. Assessment of sex differences in pharmacokinetics and pharmacodynamics of amlodipine in a bioequivalence study. Pharmacol Res. 2005; 51(5):445-52.